Skip to main content

Table 5 Percent distribution of Active Pharmaceutical Ingredient (API) in purchased ampoules of oxytocin and methylergometrine, by district

From: Accessibility and potency of uterotonic drugs purchased by simulated clients in four districts in India

 

Karnataka state

Uttar Pradesh state

 

Bagalkot

Hassan

Agra

Gorakhpur

% API

OXYTOCIN (%)

METHYL-ERGOMETRINE (%)

OXYTOCIN (%)

METHYL-ERGOMETRINE (%)

OXYTOCIN (%)

METHYL- ERGOMETRINE (%)

OXYTOCIN (%)

METHYL- ERGOMETRINE (%)

0%-25%

0.0

0.0

8.9

0.0

2.0

2.0

0.0

2.0

26-50%

0.0

9.5

2.2

0.0

6.0

2.0

0.0

0.0

51%-75%

4.2

7.1

4.4

13.0

14.0

8.0

2.0

6.0

76%-89%

27.1

83.3

22.2

82.6

16.0

42.0

10.0

36.0

WITHIN MANU-FACTURER SPECIFICA-TION (90%-110%)

66.7

0.0

60.0

4.3

50.0

46.0

78.0

56.0

111%-120%

2.1

0.0

2.2

0.0

12.0

0.0

8.0

0.0

Missing data

0.0

0.0

0.0

0.0

0.0

0.0

2.0

0.0

TOTAL

100.0

100.0

100.0

100.0

100.0

100.0

100.0

100.0

% Out of specification

33.0

100.0

40.0

95.7

50.0

54.0

22.0

44.0

Median API

98.5

84.4

98.7

85.8

99.0

89.2

102.9

90.4

N of ampoules of analysis

48

42

45

46

50

50

50

50